Literature DB >> 8371349

Packaging capacity and stability of human adenovirus type 5 vectors.

A J Bett1, L Prevec, F L Graham.   

Abstract

Adenovirus vectors are extensively used for high-level expression of proteins in mammalian cells and are receiving increasing attention for their potential use as live recombinant vaccines and as transducing viruses for use in gene therapy. Although it is commonly argued that one of the chief advantages of adenovirus vectors is their relative stability, this has not been thoroughly investigated. To examine the genetic stability of adenovirus type 5 vectors and in particular to examine the relationship between genetic stability and genome size, adenovirus vectors were constructed with inserts of 4.88 (herpes simplex virus type 1 gB), 4.10 (herpes simplex virus type 1 gB), or 3.82 (LacZ) kb combined with a 1.88-kb E3 deletion or with a newly generated 2.69-kb E3 deletion. The net excess of DNA over the wild-type (wt) genome size ranged from 1.13 to 3.00 kb or 3.1 to 8.3%. Analysis of these vectors during serial passage in tissue culture revealed that when the size exceeded 105% of the wt genome length by approximately 1.2 kb (4.88-kb insert combined with a 1.88-kb deletion), the resulting vector grew very poorly and underwent rapid rearrangement, resulting in loss of the insert after only a few passages. In contrast, vectors with inserts resulting in viral DNA close to or less than a net genome size of 105% of that of the wt grew well and were relatively stable. In general, viruses with genomes only slightly above 105% of that of the wt were unstable and the rapidity with which rearrangement occurred correlated with the size of the insert. These findings suggest that there is a relatively tight constraint on the amount of DNA which can be packaged into virions and that exceeding the limit results in a sharply decreased rate of virus growth. The resultant strong selection for variants which have undergone rearrangement, generating smaller genomes, is manifested as genetic instability of the virus population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8371349      PMCID: PMC238011     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  Adenovirus-based expression vectors and recombinant vaccines.

Authors:  F L Graham; L Prevec
Journal:  Biotechnology       Date:  1992

Review 2.  Expression of heterologous sequences in adenoviral vectors.

Authors:  K L Berkner
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

Review 3.  Adenovirus vectors as potential vaccines against herpes simplex virus.

Authors:  D C Johnson
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

4.  Widespread long-term gene transfer to mouse skeletal muscles and heart.

Authors:  L D Stratford-Perricaudet; I Makeh; M Perricaudet; P Briand
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  Expression of the APRT gene in an adenovirus vector system as a model for studying gene therapy.

Authors:  Q Wang; V Konan; M W Taylor
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

6.  Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer.

Authors:  A Mastrangeli; C Danel; M A Rosenfeld; L Stratford-Perricaudet; M Perricaudet; A Pavirani; J P Lecocq; R G Crystal
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

7.  Adenovirus as an expression vector in muscle cells in vivo.

Authors:  B Quantin; L D Perricaudet; S Tajbakhsh; J L Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

8.  Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine.

Authors:  K M Charlton; M Artois; L Prevec; J B Campbell; G A Casey; A I Wandeler; J Armstrong
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.

Authors:  T Ragot; N Vincent; P Chafey; E Vigne; H Gilgenkrantz; D Couton; J Cartaud; P Briand; J C Kaplan; M Perricaudet
Journal:  Nature       Date:  1993-02-18       Impact factor: 49.962

10.  Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutant.

Authors:  S M Cheng; S G Lee; M Ronchetti-Blume; K P Virk; S Mizutani; J W Eichberg; A Davis; P P Hung; V M Hirsch; R M Chanock
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more
  122 in total

1.  Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution.

Authors:  M Wagner; S Jonjic; U H Koszinowski; M Messerle
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 2.  Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer.

Authors:  T Hermiston
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

3.  Interaction of the adenovirus IVa2 protein with viral packaging sequences.

Authors:  W Zhang; M J Imperiale
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences.

Authors:  H Adler; M Messerle; U H Koszinowski
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  General strategy for broadening adenovirus tropism.

Authors:  Laura Fontana; Maurizio Nuzzo; Lorena Urbanelli; Paolo Monaci
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 6.  The promise of gene therapy in gastrointestinal and liver diseases.

Authors:  J Prieto; M Herraiz; B Sangro; C Qian; G Mazzolini; I Melero; J Ruiz
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

7.  Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.

Authors:  Pete Murakami; Menzo Havenga; Farah Fawaz; Ronald Vogels; Giuseppe Marzio; Erno Pungor; Jim Files; Linh Do; Jaap Goudsmit; Michael McCaman
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity.

Authors:  Chi Ying Cheng; Timra Gilson; Frédéric Dallaire; Gary Ketner; Philip E Branton; Paola Blanchette
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

9.  Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer.

Authors:  E J Kremer; S Boutin; M Chillon; O Danos
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

10.  Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5.

Authors:  C Caravokyri; K N Leppard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.